summary
Introduced
01/12/2026
01/12/2026
In Committee
02/03/2026
02/03/2026
Crossed Over
01/30/2026
01/30/2026
Passed
Dead
Introduced Session
Potential new amendment
2026 Regular Regular Session
Bill Summary
Medical cannabis program; product labels; delivery. Changes the requirements for what is included on medical cannabis product labels affixed by pharmaceutical processors to include (i) the total milligrams of tetrahydrocannabinol (THC) and cannabidiol (CBD) included in the edible cannabis product or topical cannabis product, both defined in the bill; (ii) the number of milligrams of THC and CBD in each serving of the edible cannabis product or topical cannabis product; and (iii) the total percentage of THC and CBD included in the inhalable cannabis product, defined in the bill. Under current law, the product label of any medical cannabis product is required to include the total percentage and milligrams of THC and CBD included in the product and the number of milligrams of THC and CBD in each serving.The bill also allows a pharmaceutical processor or cannabis dispensing facility to dispense or deliver cannabis products in person to a patient or such patient's registered agent, parent, or legal guardian at any residence, including a temporary residence or business. However, the bill prohibits dispensing or delivering cannabis products to (a) any military base, child day center, school, or correctional facility; (b) the State Capitol; or (c) any public gathering places, including sporting events, festivals, fairs, races, concerts, and terminals of public transportation companies. The bill also specifies that all transportation or delivery of usable cannabis, botanical cannabis, cannabis oil, or cannabis products, whether by an employee or delivery agent, shall comply with all relevant laws and regulations and provides that the Board of Directors of the Virginia Cannabis Control Authority may suspend or revoke the privileges of any employee or delivery agent to transport or deliver such products for failure to comply. The bill also provides that the 12-month stability testing period for medical cannabis products begins on the date the cannabis product is tested, rather than the date of product registration approval and that any medical cannabis product with an expiration date exceeding 12 months shall be supported by stability testing measured from the testing date, rather than the date of product registration approval. The bill contains technical amendments.
AI Summary
This bill modifies Virginia's medical cannabis program by updating product labeling requirements and expanding delivery options. Pharmaceutical processors, which are facilities that cultivate cannabis and produce cannabis products, will now need to include specific details on labels for edible and topical cannabis products, such as the total milligrams of THC (tetrahydrocannabinol, a psychoactive compound in cannabis) and CBD (cannabidiol, a non-psychoactive compound in cannabis) in the product and per serving. For inhalable cannabis products, labels must show the total percentage of THC and CBD. The bill also allows pharmaceutical processors and cannabis dispensing facilities (which are owned by pharmaceutical processors and dispense their products) to deliver cannabis products directly to patients or their registered agents, parents, or legal guardians at residences or businesses, but prohibits delivery to certain locations like military bases, schools, and public gathering places. Furthermore, it mandates that all transportation and delivery of cannabis products, whether by employees or delivery agents (independent contractors hired for delivery), must follow all relevant laws and regulations, with the Virginia Cannabis Control Authority's Board of Directors having the power to suspend or revoke delivery privileges for non-compliance.
Committee Categories
Justice
Sponsors (1)
Last Action
Fiscal Impact Statement from Department of Planning and Budget (HB391) (on 02/05/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://lis.virginia.gov/bill-details/20261/HB391 |
| Fiscal Note/Analysis - Fiscal Impact Statement from Department of Planning and Budget (HB391) | https://lis.blob.core.windows.net/files/1130603.PDF |
| BillText | https://lis.virginia.gov/bill-details/20261/HB391/text/HB391E |
| General Laws Amendment | https://lis.virginia.gov/bill-details/20261/HB391/text/HB391AHC1 |
| Subcommittee #5 Subcommittee Amendment | https://lis.virginia.gov/bill-details/20261/HB391/text/HB391AH1 |
| Fiscal Note/Analysis - Fiscal Impact Statement from Department of Planning and Budget (HB391) | https://lis.blob.core.windows.net/files/1090557.PDF |
| BillText | https://lis.virginia.gov/bill-details/20261/HB391/text/HB391 |
Loading...